193 related articles for article (PubMed ID: 22856605)
1. Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids.
Machlin ES; Sarnow P; Sagan SM
Curr Gene Ther; 2012 Aug; 12(4):301-6. PubMed ID: 22856605
[TBL] [Abstract][Full Text] [Related]
2. Discovering the first microRNA-targeted drug.
Lindow M; Kauppinen S
J Cell Biol; 2012 Oct; 199(3):407-12. PubMed ID: 23109665
[TBL] [Abstract][Full Text] [Related]
3. Prospects for nucleic acid-based therapeutics against hepatitis C virus.
Lee CH; Kim JH; Lee SW
World J Gastroenterol; 2013 Dec; 19(47):8949-62. PubMed ID: 24379620
[TBL] [Abstract][Full Text] [Related]
4. Targeting microRNA-122: walking on cutting edge of hepatitis C virus infection therapy.
Motavaf M; Safari S; Alavian SM
Acta Virol; 2014; 58(4):301-8. PubMed ID: 25518710
[TBL] [Abstract][Full Text] [Related]
5. RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.
Mutso M; Nikonov A; Pihlak A; Žusinaite E; Viru L; Selyutina A; Reintamm T; Kelve M; Saarma M; Karelson M; Merits A
PLoS One; 2015; 10(6):e0128686. PubMed ID: 26039055
[TBL] [Abstract][Full Text] [Related]
6. Development of microRNA therapeutics is coming of age.
van Rooij E; Kauppinen S
EMBO Mol Med; 2014 Jul; 6(7):851-64. PubMed ID: 24935956
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA miR-122 as a therapeutic target for oligonucleotides and small molecules.
Thomas M; Deiters A
Curr Med Chem; 2013; 20(29):3629-40. PubMed ID: 23745562
[TBL] [Abstract][Full Text] [Related]
8. Discovery of small molecule modifiers of microRNAs for the treatment of HCV infection.
Tripp VT; Young DD
Methods Mol Biol; 2014; 1103():153-63. PubMed ID: 24318893
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.
Gelley F; Zadori G; Nemes B; Fassan M; Lendvai G; Sarvary E; Doros A; Gerlei Z; Nagy P; Schaff Z; Kiss A
J Gastroenterol Hepatol; 2014 Jan; 29(1):121-7. PubMed ID: 24033414
[TBL] [Abstract][Full Text] [Related]
10. Differing prospects for the future of using gene therapy to treat infections with hepatitis B virus and hepatitis C virus.
Ely A; Arbuthnot P
Discov Med; 2015 Sep; 20(109):137-43. PubMed ID: 26463095
[TBL] [Abstract][Full Text] [Related]
11. Functional sequestration of microRNA-122 from Hepatitis C Virus by circular RNA sponges.
Jost I; Shalamova LA; Gerresheim GK; Niepmann M; Bindereif A; Rossbach O
RNA Biol; 2018; 15(8):1032-1039. PubMed ID: 29486652
[TBL] [Abstract][Full Text] [Related]
12. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
Jopling CL; Yi M; Lancaster AM; Lemon SM; Sarnow P
Science; 2005 Sep; 309(5740):1577-81. PubMed ID: 16141076
[TBL] [Abstract][Full Text] [Related]
13. Impact of a patient-derived hepatitis C viral RNA genome with a mutated microRNA binding site.
Mata M; Neben S; Majzoub K; Carette J; Ramanathan M; Khavari PA; Sarnow P
PLoS Pathog; 2019 May; 15(5):e1007467. PubMed ID: 31075158
[TBL] [Abstract][Full Text] [Related]
14. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).
Nulf CJ; Corey D
Nucleic Acids Res; 2004; 32(13):3792-8. PubMed ID: 15263060
[TBL] [Abstract][Full Text] [Related]
15. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Thibault PA; Wilson JA
Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4.
Nedaeinia R; Sharifi M; Avan A; Kazemi M; Nabinejad A; Ferns GA; Ghayour-Mobarhan M; Salehi R
Tumour Biol; 2017 Mar; 39(3):1010428317692261. PubMed ID: 28347230
[TBL] [Abstract][Full Text] [Related]
17. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma.
Young DD; Connelly CM; Grohmann C; Deiters A
J Am Chem Soc; 2010 Jun; 132(23):7976-81. PubMed ID: 20527935
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the Mysterious Interactions Between Hepatitis C Virus RNA and Liver-Specific MicroRNA-122.
Sarnow P; Sagan SM
Annu Rev Virol; 2016 Sep; 3(1):309-332. PubMed ID: 27578438
[TBL] [Abstract][Full Text] [Related]
19. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
Jopling CL; Norman KL; Sarnow P
Cold Spring Harb Symp Quant Biol; 2006; 71():369-76. PubMed ID: 17381319
[TBL] [Abstract][Full Text] [Related]
20. Interaction of host cell microRNAs with the HCV RNA genome during infection of liver cells.
Sedano CD; Sarnow P
Semin Liver Dis; 2015 Feb; 35(1):75-80. PubMed ID: 25632937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
